International Biotechnology Trust seeks to create investor returns through high-growth biotechnology investments

IBT.L/IBT LN Ticker
£269.0m Market Capitalisation
650.0p Market Share Price
706.0p NAV per share
Date & Time: 06 October 2022 08:21

International Biotechnology Trust offers investors access to the fast-growing biotechnology sector through an actively managed, diversified fund

Its award-winning fund managers at SV Health Investors are scientifically and medically trained with over 60 years of experience in this specialist sector between them.

As well as investing in a wide-ranging portfolio of global quoted biotechnology stocks, International Biotechnology Trust includes a small proportion of otherwise inaccessible carefully selected unquoted investments which have the potential to deliver additional returns over the long term. Excellent management teams, unique innovative products and strong potential for outperformance are the key criteria for inclusion in our diversified portfolio of assets.

Investing in new therapeutic drugs for the serious diseases of our age

SV Health Managers LLP

International Biotechnology Trust plc is an alternative investment fund and is managed by SV Health Managers LLP for the purposes of the Alternative Investment Fund Managers Directive 2011. SV Health Managers LLP is responsible for portfolio management and risk management in relation to the life sciences investments made by International Biotechnology Trust plc. SV Health Managers LLP is authorised and regulated by the Financial Conduct Authority (firm reference number is 409119).

Visit the SV Website →